Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Inflammatory Bowel Diseases |
Free Subscription
3 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A
Swedish Nationwide Cohort Study.
Aliment Pharmacol Ther. 2024 Feb 29. doi: 10.1111/apt.17932.
PubMed
Abstract available
Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease.
Aliment Pharmacol Ther. 2024;59:792-793.
PubMed
Editorial: Towards optimal thiopurine therapy for inflammatory bowel
disease-authors' reply.
Aliment Pharmacol Ther. 2024;59:794.
PubMed
Insurance Companies' Poor Adherence to Guidelines for Moderate to Severe
Ulcerative Colitis/Crohn's Disease Management.
Am J Gastroenterol. 2024 Feb 29. doi: 10.14309/ajg.0000000000002720.
PubMed
Abstract available
Reading of small bowel capsule endoscopy after frame reduction using an
artificial intelligence algorithm.
BMC Gastroenterol. 2024;24:80.
PubMed
Abstract available
Antibiotic exposure and risk of new-onset inflammatory bowel disease: a
systematic review and dose-response meta-analysis.
Clin Gastroenterol Hepatol. 2024 Feb 27:S1542-3565(24)00218.
PubMed
Abstract available
Risk of Cancer Recurrence in Patients With Immune-Mediated Diseases With Use of
Immunosuppressive Therapies: An Updated Systematic Review and Meta-Analysis.
Clin Gastroenterol Hepatol. 2024;22:499-512.
PubMed
Abstract available
Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel
Disease in the United States.
Clin Gastroenterol Hepatol. 2024;22:659-661.
PubMed
Abstract available
Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel
Disease, and Gastroesophageal Reflux Disease.
Dig Dis Sci. 2024 Feb 24. doi: 10.1007/s10620-024-08297.
PubMed
Abstract available
Inflammatory bowel disease is associated with multiple sclerosis or Hodgkin
lymphoma.
Eur J Gastroenterol Hepatol. 2024;36:498.
PubMed
Comparative effectiveness and safety of ustekinumab at different intervals of
maintenance phase in inflammatory bowel disease: a systematic review and
meta-analysis.
Eur J Gastroenterol Hepatol. 2024;36:359-370.
PubMed
Abstract available
Osteonecrosis in patients with inflammatory bowel disease: a systematic review
and meta-analysis.
Eur J Gastroenterol Hepatol. 2024 Feb 21. doi: 10.1097/MEG.0000000000002735.
PubMed
Abstract available
Efficacy of vedolizumab during intravenous induction therapy in ulcerative
colitis and Crohn's disease: post hoc analysis of patient-reported outcomes from
the VISIBLE 1 and 2 studies.
Eur J Gastroenterol Hepatol. 2024;36:404-415.
PubMed
Abstract available
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select
Gastrointestinal Diseases.
Gastroenterology. 2024;166:409-434.
PubMed
Abstract available
Integrating Evidence to Guide Use of Biologics and Small Molecules for
Inflammatory Bowel Diseases.
Gastroenterology. 2024;166:396-408.
PubMed
Abstract available
New AI model for neoplasia detection and characterisation in inflammatory bowel
disease.
Gut. 2024 Feb 23:gutjnl-2023-330718. doi: 10.1136/gutjnl-2023-330718.
PubMed
Early-life exposures and the microbiome: implications for IBD prevention.
Gut. 2024;73:541-549.
PubMed
Abstract available
Surgical Complications Need to Be Carefully Excluded Before Ruling Out a
Diagnosis of De Novo Crohn's Disease.
Inflamm Bowel Dis. 2024 Feb 24:izae026. doi: 10.1093.
PubMed
Causal Association Analysis of Periodontitis and Inflammatory Bowel Disease: A
Bidirectional Mendelian Randomization Study.
Inflamm Bowel Dis. 2024 Feb 26:izad188. doi: 10.1093.
PubMed
Abstract available
Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe
Ulcerative Colitis: A Case Series in the United States.
Inflamm Bowel Dis. 2024 Feb 26:izae038. doi: 10.1093.
PubMed
Comorbidity Between Inflammatory Bowel Disease and Asthma and Allergic Diseases:
A Genetically Informed Study.
Inflamm Bowel Dis. 2024 Feb 27:izae027. doi: 10.1093.
PubMed
Abstract available
Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in
Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Feb 28:izae032. doi: 10.1093.
PubMed
Abstract available
Feasibility and Acceptability of Digital Behavioral Interventions Among Black and
Hispanic Patients With Inflammatory Bowel Disease: A Randomized Pilot Study.
Inflamm Bowel Dis. 2024 Mar 1:izae034. doi: 10.1093.
PubMed
Risk of Infection in Patients With Inflammatory Bowel Disease Treated With
Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024 Mar 1:izae031. doi: 10.1093.
PubMed
Abstract available
Outcomes in Adult Inflammatory Bowel Disease Clinical Trials: Assessment of
Similarity Among Participants with Adolescent-Onset and Adult-Onset Disease.
J Crohns Colitis. 2024 Feb 26:jjae030. doi: 10.1093.
PubMed
Abstract available
Lemman Index in Children: Still an Open Question.
J Crohns Colitis. 2024;18:331-332.
PubMed
Validation of the IBD-Control Questionnaire across different sociodemographic and
clinical subgroups: secondary analysis of a nationwide electronic survey.
J Crohns Colitis. 2024;18:275-285.
PubMed
Abstract available
Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis:
Analysis of the CONSTRUCT dataset.
J Crohns Colitis. 2024;18:286-290.
PubMed
Abstract available
Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre,
Prospective, Paediatric Cohort Study.
J Crohns Colitis. 2024;18:233-245.
PubMed
Abstract available
A biomarker-stratified comparison of top-down versus accelerated step-up
treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE):
a multicentre, open-label randomised controlled trial.
Lancet Gastroenterol Hepatol. 2024 Feb 21:S2468-1253(24)00034.
PubMed
Abstract available
Use of immunomodulators in combination with infliximab in Crohn's disease: time
for a reappraisal?
Lancet Gastroenterol Hepatol. 2024 Feb 22:S2468-1253(23)00406.
PubMed
Short noncoding RNAs as predictive biomarkers for the development from
inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
PLoS One. 2024;19:e0297353.
PubMed
Abstract available
Matrix gla protein, a potential marker of tissue remodelling and physiological
ageing of the gut in crohn's disease.
Scand J Gastroenterol. 2024;59:296-303.
PubMed
Abstract available
Risk of malignancy in a high-incidence population-based cohort of Faroese
patients with inflammatory bowel disease from 1960 to 2020 - a Faroese IBD cohort
study.
Scand J Gastroenterol. 2024 Feb 26:1-8. doi: 10.1080/00365521.2024.2320712.
PubMed
Abstract available
[Takayasu arteritis after COVID-19 infection in a 26-year-old female patient with
Crohn's disease].
Z Gastroenterol. 2024 Feb 28. doi: 10.1055/a-2187-9295.
PubMed
Abstract available
Thank you for your interest in scientific medicine.